Global Celiac Diseases Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	162 Pages	TechNavio	June, 2024	INF19006765

Best Price Guarantee
Price	from $2,500
Length	162 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19006765

Global Celiac Diseases Drugs Market 2024-2028

The celiac diseases drugs market is forecasted to grow by USD 1101.1 mn during 2023-2028, accelerating at a CAGR of 21.21% during the forecast period. The report on the celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac diseases, and government initiatives.

Technavio's celiac diseases drugs market is segmented as below:

By Therapy

First line treatment
Second-line treatment

By Route Of Administration

Oral
Parenteral

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, increasing promising developments in celiac treatment and rising prevalence and diagnosis will lead to sizable demand in the market.

The report on the celiac diseases drugs market covers the following areas:

Celiac diseases drugs market sizing
Celiac diseases drugs market forecast
Celiac diseases drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors that include 9 Meters Biopharma Inc, Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech BV, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ImmunogenX Inc., Johnson and Johnson Services Inc., Precigen Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, and Zedira GmbH. Also, the celiac diseases drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Therapy; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Celiac Diseases Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million); 4.2 Therapy segment analysis 2018 - 2022; Historic Market Size - Therapy Segment 2018 - 2022 ($ million); 4.3 Route of Administration segment analysis 2018 - 2022; Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy: 6.1 Market segments; Chart on Therapy - Market share 2023-2028 (%); Data Table on Therapy - Market share 2023-2028 (%); 6.2 Comparison by Therapy; Chart on Comparison by Therapy; Data Table on Comparison by Therapy; 6.3 First line treatment - Market size and forecast 2023-2028; Chart on First line treatment - Market size and forecast 2023-2028 ($ million); Data Table on First line treatment - Market size and forecast 2023-2028 ($ million); Chart on First line treatment - Year-over-year growth 2023-2028 (%); Data Table on First line treatment - Year-over-year growth 2023-2028 (%); 6.4 Second-line treatment - Market size and forecast 2023-2028; Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million); Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million); Chart on Second-line treatment - Year-over-year growth 2023-2028 (%); Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Therapy; Market opportunity by Therapy ($ million); Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by Route of Administration: 7.1 Market segments; Chart on Route of Administration - Market share 2023-2028 (%); Data Table on Route of Administration - Market share 2023-2028 (%); 7.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 7.3 Oral - Market size and forecast 2023-2028; Chart on Oral - Market size and forecast 2023-2028 ($ million); Data Table on Oral - Market size and forecast 2023-2028 ($ million); Chart on Oral - Year-over-year growth 2023-2028 (%); Data Table on Oral - Year-over-year growth 2023-2028 (%); 7.4 Parenteral - Market size and forecast 2023-2028; Chart on Parenteral - Market size and forecast 2023-2028 ($ million); Data Table on Parenteral - Market size and forecast 2023-2028 ($ million); Chart on Parenteral - Year-over-year growth 2023-2028 (%); Data Table on Parenteral - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Adaptive Biotechnologies Corp.; Adaptive Biotechnologies Corp. - Overview; Adaptive Biotechnologies Corp. - Product / Service; Adaptive Biotechnologies Corp. - Key news; Adaptive Biotechnologies Corp. - Key offerings; 12.4 Almirall SA; Almirall SA - Overview; Almirall SA - Product / Service; Almirall SA - Key news; Almirall SA - Key offerings; 12.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.6 AMYRA Biotech AG; AMYRA Biotech AG - Overview; AMYRA Biotech AG - Product / Service; AMYRA Biotech AG - Key offerings; 12.7 BioLineRx Ltd.; BioLineRx Ltd. - Overview; BioLineRx Ltd. - Product / Service; BioLineRx Ltd. - Key offerings; 12.8 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.9 Calypso Biotech BV; Calypso Biotech BV - Overview; Calypso Biotech BV - Product / Service; Calypso Biotech BV - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; 12.12 ImmunogenX Inc.; ImmunogenX Inc. - Overview; ImmunogenX Inc. - Product / Service; ImmunogenX Inc. - Key offerings; 12.13 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.14 Precigen Inc.; Precigen Inc. - Overview; Precigen Inc. - Key offerings; 12.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.16 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; 12.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Therapy - Market share 2023-2028 (%); Exhibits33: Data Table on Therapy - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Therapy; Exhibits35: Data Table on Comparison by Therapy; Exhibits36: Chart on First line treatment - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on First line treatment - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on First line treatment - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on First line treatment - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Second-line treatment - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Therapy ($ million); Exhibits45: Data Table on Market opportunity by Therapy ($ million); Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%); Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Route of Administration; Exhibits49: Data Table on Comparison by Route of Administration; Exhibits50: Chart on Oral - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Oral - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Parenteral - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Parenteral - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Parenteral - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Route of Administration ($ million); Exhibits59: Data Table on Market opportunity by Route of Administration ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share by geography 2023-2028 (%); Exhibits62: Data Table on Market share by geography 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity by geography ($ million); Exhibits102: Data Tables on Market opportunity by geography ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: Adaptive Biotechnologies Corp. - Overview; Exhibits110: Adaptive Biotechnologies Corp. - Product / Service; Exhibits111: Adaptive Biotechnologies Corp. - Key news; Exhibits112: Adaptive Biotechnologies Corp. - Key offerings; Exhibits113: Almirall SA - Overview; Exhibits114: Almirall SA - Product / Service; Exhibits115: Almirall SA - Key news; Exhibits116: Almirall SA - Key offerings; Exhibits117: Amgen Inc. - Overview; Exhibits118: Amgen Inc. - Product / Service; Exhibits119: Amgen Inc. - Key news; Exhibits120: Amgen Inc. - Key offerings; Exhibits121: AMYRA Biotech AG - Overview; Exhibits122: AMYRA Biotech AG - Product / Service; Exhibits123: AMYRA Biotech AG - Key offerings; Exhibits124: BioLineRx Ltd. - Overview; Exhibits125: BioLineRx Ltd. - Product / Service; Exhibits126: BioLineRx Ltd. - Key offerings; Exhibits127: Bristol Myers Squibb Co. - Overview; Exhibits128: Bristol Myers Squibb Co. - Product / Service; Exhibits129: Bristol Myers Squibb Co. - Key news; Exhibits130: Bristol Myers Squibb Co. - Key offerings; Exhibits131: Calypso Biotech BV - Overview; Exhibits132: Calypso Biotech BV - Product / Service; Exhibits133: Calypso Biotech BV - Key offerings; Exhibits134: GlaxoSmithKline Plc - Overview; Exhibits135: GlaxoSmithKline Plc - Business segments; Exhibits136: GlaxoSmithKline Plc - Key news; Exhibits137: GlaxoSmithKline Plc - Key offerings; Exhibits138: GlaxoSmithKline Plc - Segment focus; Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits142: ImmunogenX Inc. - Overview; Exhibits143: ImmunogenX Inc. - Product / Service; Exhibits144: ImmunogenX Inc. - Key offerings; Exhibits145: Johnson and Johnson Services Inc. - Overview; Exhibits146: Johnson and Johnson Services Inc. - Business segments; Exhibits147: Johnson and Johnson Services Inc. - Key news; Exhibits148: Johnson and Johnson Services Inc. - Key offerings; Exhibits149: Johnson and Johnson Services Inc. - Segment focus; Exhibits150: Precigen Inc. - Overview; Exhibits151: Precigen Inc. - Key offerings; Exhibits152: Sanofi SA - Overview; Exhibits153: Sanofi SA - Business segments; Exhibits154: Sanofi SA - Key news; Exhibits155: Sanofi SA - Key offerings; Exhibits156: Sanofi SA - Segment focus; Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits161: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits162: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits163: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits164: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits165: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits166: Inclusions checklist; Exhibits167: Exclusions checklist; Exhibits168: Currency conversion rates for US$; Exhibits169: Research methodology; Exhibits170: Information sources; Exhibits171: Data validation; Exhibits172: Validation techniques employed for market sizing; Exhibits173: Data synthesis; Exhibits174: 360 degree market analysis; Exhibits175: List of abbreviations